Does METOPROLOL Cause Peripheral arterial occlusive disease? 70 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Peripheral arterial occlusive disease have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.2% of all adverse event reports for METOPROLOL.
70
Reports of Peripheral arterial occlusive disease with METOPROLOL
0.2%
of all METOPROLOL reports
1
Deaths
55
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From METOPROLOL?
Of the 70 reports, 1 (1.4%) resulted in death, 55 (78.6%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Peripheral arterial occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Peripheral arterial occlusive disease?
NILOTINIB (319)
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
IMATINIB (86)
ASPIRIN (77)
ATORVASTATIN (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)
ETELCALCETIDE (63)
Which METOPROLOL Alternatives Have Lower Peripheral arterial occlusive disease Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE